These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH. Clin Orthop Relat Res; 2024 Dec 01; 482(12):2193-2208. PubMed ID: 39051924 [Abstract] [Full Text] [Related]
4. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020. de Groot TM, Ramsey D, Groot OQ, Fourman M, Karhade AV, Twining PK, Berner EA, Fenn BP, Collins AK, Raskin K, Lozano S, Newman E, Ferrone M, Doornberg JN, Schwab JH. Clin Orthop Relat Res; 2023 Dec 01; 481(12):2419-2430. PubMed ID: 37229565 [Abstract] [Full Text] [Related]
6. A comprehensive nomogram for assessing the prognosis of non-small cell lung cancer patients receiving immunotherapy: a prospective cohort study in China. Li H, Yuan Y, Xu Q, Liang G, Hu Z, Li X, Zhang W, Lei H. Front Immunol; 2024 Dec 01; 15():1487078. PubMed ID: 39635526 [Abstract] [Full Text] [Related]
12. Comparison of efficacy and safety of neoadjuvant immunochemotherapy in young and elderly patients with IIA-IIIB non-small-cell lung cancer in real-world practice. Liu J, Huang X, Yang Y, Lv W, Wang Y, Xia P, Hu J. BMC Pulm Med; 2024 Nov 29; 24(1):592. PubMed ID: 39614293 [Abstract] [Full Text] [Related]
13. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N, Davenport R, Thomas H, Fox E, Lucas J, Evans A, Massou E, Sharma R, Shanmugaranjan S, Rourke C, Newton A, Deary A, Dallas N, Fitzpatrick-Creamer C, Podbielski JM, Wade CE, Edwards A, Benger J, Morris S, Cotton BA, Piercy J, Green L, Brohi K, Stanworth S. Health Technol Assess; 2024 Nov 29; 28(76):1-69. PubMed ID: 39545850 [Abstract] [Full Text] [Related]
17. Kirtsoglou E, Simpson B, Salisbury L, Baraitser L. ; 2020 Nov 29. PubMed ID: 36137063 [Abstract] [Full Text] [Related]
18. Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel predictor using interpretable machine learning. Wang Y, Pan Z, Li S, Cai H, Huang Y, Zhuang J, Liu X, Lu X, Guan G. Eur J Surg Oncol; 2024 Dec 29; 50(12):108738. PubMed ID: 39395242 [Abstract] [Full Text] [Related]
19. Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis. Yang Y, Chen W, Dong L, Duan L, Gao P. Clin Transl Oncol; 2024 Oct 29; 26(10):2488-2502. PubMed ID: 38625495 [Abstract] [Full Text] [Related]